Trial Radar KI | ||
|---|---|---|
Die klinische Studie NCT05553275 für Schwangerschaftsdiabetes, Prägestationsdiabetes ist abgeschlossen. In der Kartenansicht des Klinische Studien Radar und den KI-Entdeckungstools finden Sie alle Details. Oder stellen Sie hier Ihre Fragen. | ||
Eine Studie entspricht den Filterkriterien
Kartenansicht
Permissive Intrapartum Glucose Control 96
Die Details der klinischen Studie sind hauptsächlich auf Englisch verfügbar. Trial Radar KI kann jedoch helfen! Klicken Sie einfach auf 'Studie erklären', um die Informationen zur Studie in der ausgewählten Sprache anzuzeigen und zu besprechen.
Die klinische Studie NCT05553275 untersuchte Schwangerschaftsdiabetes, Prägestationsdiabetes als interventionsstudie und hat den Status abgeschlossen. Die Studie begann am 5. Oktober 2022 mit 96 Teilnehmern. Sie wurde durchgeführt von The University of Texas Health Science Center, Houston und am 13. August 2023 abgeschlossen. Die Daten von ClinicalTrials.gov wurden zuletzt am 14. Mai 2024 aktualisiert.
Kurzbeschreibung
The purpose of this study is to assess whether permissive intrapartum glycemic control compared to usual care would lead to similar rate of neonatal hypoglycemia among people with diabetes.
Offizieller Titel
Permissive Intrapartum Glucose Control: An Equivalence Randomized Control Study (PERMIT)
Erkrankungen
SchwangerschaftsdiabetesPrägestationsdiabetesWeitere Studien-IDs
- HSC-MS-22-0577
NCT-Nummer
Studienbeginn (tatsächlich)
2022-10-05
Zuletzt aktualisiert
2024-05-14
Studienende (vorauss.)
2023-08-13
Geplante Rekrutierung
96
Studientyp
Interventionsstudie
PHASE
Nicht zutreffend
Status
Abgeschlossen
Stichwörter
Diabetes Mellitus
Primäres Ziel
Behandlung
Zuteilungsmethode
Randomisiert
Interventionsmodell
Parallel
Verblindung
Keine (offene Studie)
Studienarme/Interventionen
| Teilnehmergruppe/Studienarm | Intervention/Behandlung |
|---|---|
Aktives VergleichspräparatGroup 1:Usual Care | Übliche Versorgung Blood sugar evaluation (accuchecks) every four hours in latent labor and every 2 hours in active labor.Participants will be routinely managed with maintenance fluids of lactated ringers during latent labor and lactated ringers with dextrose 5% in active labor. Blood sugars of more than 110 mg/dl at any time point in labor will be treated with an insulin drip as follows:
Regular insulin (100 units) in 100cc of normal...Mehr anzeigen |
ExperimentellGroup 2: Permissive Care | Permissive intrapartum glucose control Blood sugar evaluation (accuchecks) every four hours in latent labor and every 2 hours in active labor.Participants will be routinely management with maintenance fluids of lactated ringers during latent labor and lactated ringers with dextrose 5% in active labor.Blood sugars of more than 180 mg/dl at any time point in labor will be treated with an insulin drip as follows:
Regular insulin (100 units) in 100cc of norm...Mehr anzeigen |
Hauptergebnismessungen
Nebenergebnismessungen
| Ergebnismessung | Beschreibung der Messung | Zeitrahmen |
|---|---|---|
first neonatal blood glucose level measured in mg/dL | up to 2 hours of life prior to first feed |
| Ergebnismessung | Beschreibung der Messung | Zeitrahmen |
|---|---|---|
Number of intrapartum glucose measurements | During Labor(for up to 200 hours) | |
Mean maternal glucose values in mg/dl | during latent labor(for up to 200 hours) | |
Mean maternal glucose values in mg/dl | during active labor(for up to 200 hours) | |
Overall mean maternal glucose values in mg/dl | in all of labor(for up to 200 hours) | |
Number of participants that have hyperglycemia episodes | Hyperglycemia is defined as blood sugar levels greater than 200 mg/dl | during labor( for up to 200 hours) |
Number of participants that have hypoglycemia episodes | Hypoglycemia is defined as blood sugar levels less than or equal to 60 mg/dl or symptomatic or requiring IV dextrose | during labor(for up to 200 hours) |
Number of participants that have Diabetic Ketoacidosis | Diabetic Ketoacidosis includes uncontrolled hyperglycemia, anion gap metabolic acidosis, and ketosis | during labor(for up to 200 hours) |
Maximum insulin Glucose tolerance test (GTT) rate | during labor(for up to 200 hours) | |
Number of participants that utilize insulin drip | during labor(for up to 200 hours) | |
Number of participants that undergo primary cesarean section | at time of delivery | |
Number of participants that have Postpartum hemorrhage | Postpartum hemorrhage is defined as greater than or equal to 1000ml or need for blood transfusion | from discharge until 6 months after birth |
Number pf participants that have Intra-amniotic Infection | Intra-amniotic Infection is defined as clinically diagnosed infection of the uterine environment | intrapartum or within 24 hours of delivery |
Number pf participants that have endometriosis | Endometritis is defined as clinically diagnosed uterine infection | Between 24 hours after delivery to 6 weeks of delivery |
Number pf participants that have wound complications | Wound complications is defined as superficial or deep infections, fascial dehiscence | within 6 weeks of delivery |
Number pf participants that require blood product transfusion | during admission (for up to 6 weeks after neonate delivery) | |
Resource utilization during labor as assessed by the number of accuchecks done | during delivery admission (labor or induction/augmentation) until delivery defined as time patient is admitted to labor and delivery until birth time of neonate, for up to 200 hours | |
Resource utilization during labor as assessed by the number of nurses utilized | during delivery admission (labor or induction/augmentation) until delivery defined as time patient is admitted to labor and delivery until birth time of neonate, for up to 200 hours | |
Total facility and physician costs for all the services provided to the mothers | From maternal admission time to maternal discharge time(upto 6 months form admission date) | |
Total facility and physician costs for all the services provided to the neonates | from birth time to discharge time defined as birth time of neonate until neonate is discharged from the hospital, up to 1 year | |
Total nurse time cost for monitoring the patients during labor | From admission time to delivery time defined as time patient is admitted to labor and delivery until birth time of neonate, for up to 200 hours | |
Number of gestational diabetes participants that do an oral glucose tolerance test (OGTT) | within 6- 8 weeks of delivery | |
Neonatal C-peptide levels from cord blood | at time of delivery | |
Number of neonates that have blood glucose level less than 40 mg/dL | within the first 24 hours of life | |
Number of neonates that have blood glucose level less than 40 mg/dL | during birth admission defined as birth time of neonate until neonate is discharged from hospital, up to 1 year | |
Number of neonates that need oral glucose supplementation | during birth admission defined as birth time of neonate until neonate is discharged from hospital, up to 1 year | |
Number of neonates that need IV glucose | during birth admission defined as birth time of neonate until neonate is discharged from hospital, up to 1 year | |
Lowest neonatal glucose level | during birth admission defined as birth time of neonate until neonate is discharged from hospital, up to 1 year | |
Mean neonatal glucose level in first 24 hours of life | during birth admission defined as birth time of neonate until neonate is discharged from hospital, up to 1 year | |
Lowest neonatal glucose level | first 24 hours of life | |
Number of neonates that required shoulder dystocia | Shoulder dystocia is defined as the need for any extra maneuvers, other than gentle downward traction of the fetal head to deliver the fetal body after the fetal head has been delivered | at time of delivery |
Number of neonates that had birth injury | Birth injury as defined as skull, clavicular, humerus fracture, or brachial plexus | from birth and during admission defined as birth time of neonate until neonate is discharged from hospital, up to 1 year |
Number of neonates that had respiratory distress | Respiratory distress is defined as the need for at least 4 hours of respiratory support with supplemental oxygen, continuous positive airway pressure, or ventilation | first 24 hours of life |
Number of fetal deaths | during labor defined as time patient is admitted to labor and delivery until birth time of neonate, for up to 200 hours | |
Number of neonatal deaths | within 28 days of birth | |
Number of neonates with Apgar score of less than 7 | 5 minutes from birth | |
Number of neonates that are admitted to Neonatal intensive care unit (NICU) | from birth up to 6 months from birth | |
Number of days neonates are admitted to NICU | from birth up to 6 months from birth | |
Number of neonates that have neonatal hyperbilirubinemia requiring phototherapy | during admission defined as birth time of neonate until neonate is discharged from hospital, up to 1 year | |
Maximum Bilirubin level | during admission defined as birth time of neonate until neonate is discharged from hospital, up to 1 year | |
Number of neonates that have hypocalcemia | during admission defined as birth time of neonate until neonate is discharged from hospital, up to 1 year | |
Number of neonates that have Necrotizing Enterocolitis | from birth up to 6 months from birth | |
Number of neonates that are small for gestational age | Small for gestational age is defined as a weight below 10th percentile of the expected value according to gestational age | at birth |
Number of neonates that are large for gestational age | Large for gestational age is defined as a weight above 90th percentile of the expected value according to gestational age | at birth |
Number of neonates that have Macrosomia | Macrosomia is defined as weight more than 4000 grams | at time of birth |
Eignungskriterien
Zugelassene Altersgruppen
Erwachsene, Ältere Erwachsene
Mindestalter
18 Years
Zugelassene Geschlechter
Weiblich
- Singleton gestation
- Presenting for intrapartum management (induction, labor, augmentation)
- Any diagnosis of Type 1 Diabetes Mellitus(T1DM), Type 2 Diabetes Mellitus (T2DM), or Gestational Diabetes
- English or Spanish fluency
- Major fetal anomalies affecting glucose metabolism
- Multiple Gestation
- Incarcerated subjects
- less than 34 weeks gestation of pregnancy
- Planned cesarean delivery
- Utilizing insulin pump during labor
- Stillbirth
- Presenting in Diabetic ketoacidosis(DKA)
The University of Texas Health Science Center, HoustonVerantwortliche Partei
Ghamar Bitar, Hauptprüfer, Fellow, The University of Texas Health Science Center, Houston
Keine Kontaktdaten vorhanden
1 Studienstandorte in 1 Ländern
Texas
The University of Texas Health Science Center at Houston, Houston, Texas, 77030, United States